| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/24/2011 | WO2011021616A1 Novel protein having β-glucosidase activity, and use thereof |
| 02/24/2011 | WO2011021508A1 Marker for predicting therapeutic effect on hepatitis c, method for predicting therapeutic effect on hepatitis c, and prophylaxis or therapeutic agent for hepatitis c |
| 02/24/2011 | WO2011021386A1 Cstf2 for target genes of lung cancer therapy and diagnosis |
| 02/24/2011 | WO2011021372A1 Food product containing starch gel |
| 02/24/2011 | WO2011021308A1 NUCLEIC ACID MOLECULE HAVING AFFINITY WITH IgG ANTIBODY DERIVED FROM RODENT, BINDING AGENT, DETECTION REAGENT, AND DETECTION KIT |
| 02/24/2011 | WO2011021221A2 Compositions for spinal cord injury |
| 02/24/2011 | WO2011021190A1 Plants producing high crop yield |
| 02/24/2011 | WO2011021171A1 Preventing and curing beneficial insect diseases via plant transcribed molecules |
| 02/24/2011 | WO2011021166A1 Meganuclease variants cleaving a dna target sequence from the human lysosomal acid alpha-glucosidase gene and uses thereof |
| 02/24/2011 | WO2011021102A2 Compositions and methods for intramolecular nucleic acid rearrangement |
| 02/24/2011 | WO2011021062A1 Meganuclease variants cleaving a dna target sequence from the human lysosomal acid alpha-glucosidase gene and uses thereof |
| 02/24/2011 | WO2011020910A1 Polypeptides having isoamylase activity and polynucleotides encoding same |
| 02/24/2011 | WO2011020866A2 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
| 02/24/2011 | WO2011020865A1 Apolipoprotein l- i variants and their use |
| 02/24/2011 | WO2011020797A2 Disease resistant tomato plants |
| 02/24/2011 | WO2011020790A1 Treatment of patients after stent implantation or balloon dilatation and drug eluting stents |
| 02/24/2011 | WO2011020746A1 Plants having enhanced yield-related traits and a method for making the same |
| 02/24/2011 | WO2011020710A2 Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions |
| 02/24/2011 | WO2011020497A1 C-terminal mutant of apolipoprotein l-i and its therapeutical or prophylactic use |
| 02/24/2011 | WO2011020319A1 Fusion protein regulating plasma glucose and lipid, its preparation method and use |
| 02/24/2011 | WO2011020247A1 Replica barcode selection assay |
| 02/24/2011 | WO2011020198A1 Dna ligands for aflatoxin and zearalenone |
| 02/24/2011 | WO2011020183A1 Screening of protein candidates |
| 02/24/2011 | WO2011020163A1 Plant gene expression |
| 02/24/2011 | WO2011002063A8 Cellulase preparation containing endoglucanases derived from two different types of microorganisms |
| 02/24/2011 | WO2010148065A9 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1 |
| 02/24/2011 | WO2010148013A3 Lipid formulated dsrna targeting the pcsk9 gene |
| 02/24/2011 | WO2010145843A9 Method for isolating nucleic acids |
| 02/24/2011 | WO2010140827A9 Automatic detection kit for hla alleles by real-time polymerase chain reaction |
| 02/24/2011 | WO2010129919A9 Mirna expression in allergic disease |
| 02/24/2011 | WO2010117750A3 Engineering broad-spectrum disease resistance against haustorium-forming pathogens using rpw8 as a delivery vehicle |
| 02/24/2011 | WO2010114615A3 A facile system for encoding unnatural amino acids in mammalian cells |
| 02/24/2011 | WO2010111409A3 Pluripotent stem cells |
| 02/24/2011 | WO2010110591A3 Environmental stress-inducible promoter, and use thereof |
| 02/24/2011 | WO2010108126A3 Reprogramming compositions and methods of using the same |
| 02/24/2011 | WO2010107946A3 Use of thermostable endonucleases for generating reporter molecules |
| 02/24/2011 | WO2010105235A3 Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy |
| 02/24/2011 | WO2010104749A3 Antigen presenting cell targeted cancer vaccines |
| 02/24/2011 | WO2010104588A3 Compositions and methods for characterizing and treating neoplasia |
| 02/24/2011 | WO2010103015A9 Microrna for diagnostic and therapeutic purposes in cardiovascular diseases |
| 02/24/2011 | WO2010099501A3 Transaminase biocatalysts |
| 02/24/2011 | WO2010099127A3 Free circulating dna bio-markers and their applications |
| 02/24/2011 | WO2010095879A3 Sirna to be bound to transcripts of apoptosis-related genes, and compositions for treating cancer using same |
| 02/24/2011 | WO2010093692A3 Irreversible electroporation and tissue regeneration |
| 02/24/2011 | WO2010093223A3 Target substance detection method using aptamer |
| 02/24/2011 | WO2010088522A3 Novel lowered affinity antibodies and uses therefor |
| 02/24/2011 | WO2010075574A3 Enone reductases |
| 02/24/2011 | WO2010011404A3 Vectors for delivery of light-sensitive proteins and methods of use |
| 02/24/2011 | WO2010007372A8 Transgenic rodent expressing truncated disc1 |
| 02/24/2011 | WO2009147382A3 Eurakyotic secretion signal sequence for recombinant expression in prokaryotes |
| 02/24/2011 | WO2009135603A8 Method of generating hypoallergenic glycoproteins in mutated or transgenic plants or plant cells, and mutated or transgenic plants and plant cells for generating hypoallergenic glycoproteins |
| 02/24/2011 | WO2008122053A3 Compositions, kits and related methods for the detection and/or monitoring of pseudomonas aeruginosa |
| 02/24/2011 | WO2008020318A3 Non-viral compositions and methods for transfecting gut cells in vivo |
| 02/24/2011 | US20110047660 Compositions and related methods for modulating alkaloid production by controlling pmt promoter activation mediated by transcriptional factors erf and myc |
| 02/24/2011 | US20110047659 Transgenic Plants With Enhanced Agronomic Traits |
| 02/24/2011 | US20110047656 Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose |
| 02/24/2011 | US20110047655 Novel frt recombination sites and methods of use |
| 02/24/2011 | US20110047652 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 02/24/2011 | US20110047650 Yield enhancement in plants by modulation of zea mays protein kinase-like gene (zmpkl1) |
| 02/24/2011 | US20110047649 Nitrogen responsiveness in plants through the expression of pathways for the formation and catabolism of novel n-rich compounds |
| 02/24/2011 | US20110047648 Promoters and methods thereof |
| 02/24/2011 | US20110047647 Functional expression of shuffled yeast nitrate transporter (ynt1) in maize to improve nitrate uptake under low nitrate environment |
| 02/24/2011 | US20110047646 Armyworm Insect Resistance Management in Transgenic Plants |
| 02/24/2011 | US20110047645 Compositions and Methods of Using RNA Interference for Control of Nematodes |
| 02/24/2011 | US20110047644 Compositions and methods for the modification of gene transcription |
| 02/24/2011 | US20110047643 Dry bean line 08550815 |
| 02/24/2011 | US20110047641 Soybean Cultivar 8734242 |
| 02/24/2011 | US20110047640 Soybean Cultivar 8647195 |
| 02/24/2011 | US20110047639 Soybean Cultivar 8536465 |
| 02/24/2011 | US20110047638 Soybean Cultivar 8322144 |
| 02/24/2011 | US20110047637 Soybean Cultivar 8235453 |
| 02/24/2011 | US20110047635 Methods and compositions for transposon-mediated transgenesis |
| 02/24/2011 | US20110046360 ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR |
| 02/24/2011 | US20110046352 Disease-resistant plants and method of constructing the same |
| 02/24/2011 | US20110046351 Mutant proteins and methods for selecting them |
| 02/24/2011 | US20110046209 RNA-Induced Translational Silencing and Cellular Apoptosis |
| 02/24/2011 | US20110046208 Nucleolar targeting of therapeutics against hiv |
| 02/24/2011 | US20110046207 C5a binding nucleic acids |
| 02/24/2011 | US20110046204 Human Zip1, Zinc and Citrate for Prostate Cancer Screening |
| 02/24/2011 | US20110046203 Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
| 02/24/2011 | US20110046201 Methods and compositions for seamless cloning of nucleic acid molecules |
| 02/24/2011 | US20110046073 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling |
| 02/24/2011 | US20110046042 Long Interspersed Nuclear Element Polypeptide Compositions and Methods of Use Thereof |
| 02/24/2011 | US20110046014 Promoter and plasmid system for genetic engineering |
| 02/24/2011 | US20110046011 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof |
| 02/24/2011 | US20110046005 Method and nucleic acids for the analysis of colon cell proliferative disorders |
| 02/24/2011 | US20110045605 Characterization of Granulocytic Ehrlichia and Methods of Use |
| 02/24/2011 | US20110045604 Molecular affinity clamp technology and uses thereof |
| 02/24/2011 | US20110045594 Genetic remodeling in bifidobacterium |
| 02/24/2011 | US20110045593 Transgenically mitigating the establishment and spread of transgenic algae in natural ecosystems by suppressing the activity of carbonic anhydrase |
| 02/24/2011 | US20110045592 Methods of genome installation in a recipient host cell |
| 02/24/2011 | US20110045591 Controlled Activation of Non-LTR Retrotransposons in Mammals |
| 02/24/2011 | US20110045589 Methods Of Controlling Proliferation And Differentiation Of Stem And Progenitor Cells |
| 02/24/2011 | US20110045587 Toxin peptide therapeutic agents |
| 02/24/2011 | US20110045586 Methods and compositions for expressing negative-sense viral rna in canine cells |
| 02/24/2011 | US20110045584 Expression vector suitable for expression of a coding sequence for gene therapy |
| 02/24/2011 | US20110045583 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
| 02/24/2011 | US20110045574 Chromatography medium |
| 02/24/2011 | US20110045573 Alanine 2, 3-aminomutase |
| 02/24/2011 | US20110045572 Protein variants having modified immunogenicity |